Appendix 2B. | Search strategy for Embase until 6th December 2021 |
Search | Query | Items found |
---|---|---|
#36 | exp biological product/ | 769,484 |
#37 | exp antimetabolite/ | 646,897 |
#38 | exp immunocompromised patient/ | 22,322 |
#39 | exp glucocorticoid/ | 782,787 |
#40 | exp prednisolone/ | 136,731 |
#41 | exp prednisone/ | 185,595 |
#42 | exp betamethasone/ | 18,234 |
#43 | exp hydrocortisone/ | 133,836 |
#44 | exp dexamethasone/ | 168,961 |
#45 | exp methylprednisolone/ | 108,608 |
#46 | exp triamcinolone/ | 15,553 |
#47 | exp triamcinolone acetonide/ | 15,801 |
#48 | exp cytostatic agent/ | 9,376 |
#49 | exp methotrexate/ | 193,714 |
#50 | exp cyclophosphamide/ | 233,203 |
#51 | exp azathioprine/ | 100,742 |
#52 | exp cyclosporin derivative/ | 1,985 |
#53 | exp cyclosporine/ | 21,992 |
#54 | exp mycophenolic acid/ | 21,344 |
#55 | exp rituximab/ | 94,656 |
#56 | exp Janus kinase inhibitor/ | 22,087 |
#57 | exp salazosulfapyridine/ | 27,606 |
#58 | exp antimalarial agent/ | 158,478 |
#59 | exp hydroxychloroquine/ | 38,378 |
#60 | exp chloroquine/ | 41,330 |
#61 | exp leflunomide/ | 13,592 |
#62 | exp tumor necrosis factor inhibitor/ | 107,173 |
#63 | exp adalimumab/ | 39,695 |
#64 | exp ustekinumab/ | 9,673 |
#65 | exp omalizumab/ | 9,749 |
#66 | exp infliximab/ | 57,075 |
#67 | exp etanercept/ | 34,838 |
#68 | exp certolizumab pegol/ | 8,058 |
#69 | exp interleukin 1 receptor blocking agent/ | 14,930 |
#70 | exp abatacept/ | 10,920 |
#71 | (antirheumatic agent* or immunosuppressive agent* or biosimilar pharmaceutical* or biological control agent* or biological factor* or biological product* or antimetabolite* or medically compromised patient* or immunocompromised host* or immunocompromised patient* or glucocorticoid* or cytostatic agent* or triamcinolone hexacetonide or baricitinib or upadacitinib or tofacitinib or golimumab or anakinra or tocilizumab or secukinumab or belimumab or guselkumab or ixekizumab or brodalumab or tildrakizumab or secukinumab or costimulation modulator or co-stimulation modulator or interleukin 1 antagonist* or interleukin 1 inhibitor* or interleukin 6 antagonist* or interleukin 6 inhibitor* or interleukin 17 antagonist* or interleukin 17 inhibitor* or interleukin 12 antagonist* or interleukin 12 inhibitor* or interleukin 23 antagonist* or interleukin 23 inhibitor*).mp. [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword heading word, floating subheading word, candidate term word] | 413,368 |
#72 | ((CD20 or CD-20) and (immunoglobulin or antibody)).mp. [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword heading word, floating subheading word, candidate term word] | 24,342 |
#73 | 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64 or 65 or 66 or 67 or 68 or 69 or 70 or 71 or 72 | 5,454,806 |
#74 | 6 and 30 | 589 |
#75 | 6 and 73 | 3,364 |
#76 | 74 or 75 | 3,820 |
#77 | limit 76 to english | 3,654 |
#78 | exp animal/ | 28,033,905 |
#79 | exp human/ | 23,179,392 |
#80 | 78 not 79 | 4,854,513 |
#81 | 77 not 80 | 2,715 |